Purdue Pharma’s Payments to Sacklers Soared Amid Opioid Crisis

0
122

A new audit finds that the family directed $10.7 billion from the drugmaker to family-controlled trusts and holding companies, as legal pressure tightened around Purdue.
Source: Test 1